Classic Bullish divergence on both the 4hr and daily timeframe. Price has formed a descending wedge pattern and looks to have broken out. Support has been found at the 0.886 fibonacci retracement level which is also a historical daily resistance level before running to ATH.
Bullish engulfing candle today. The .886 fib level may have been the landing pad, but the bottom is not always the bottom. Biotech has been up and down so I am approaching this sector with caution for now. I have noted some biotech making daily or every other day yearly low and EBS made a new low yesterday and today although the 2 lows almost matched 58.79...
Another biotech. Does look like something gotta give soon. This stock is not afraid to gap down, so not for the faint of heart (o: EBS can gap up as well as it can gap down. Frequent gapping can indicate volatility. Not a recommendation. EBS pulled back on the 2nd leg a bit past the 0.618 fib level. If this were a Gartley pattern the landing pad would be...
bullish buy at 98.21, conserv buy at 94.61; 102.23 target, stop loss 89.64; r/r 1.93
Hello traders, EMERGENT BIOSOLUTIONS is in a fake bearish push with a return of executed buy volume and a large hammer candle. Looking at the TIMEFRAME M1 we see a dash with a negotiated buy volume return, she came to the base of the bollinger to test it. And move up to the comfort zone to check it again. There is a great chance of breaking the price, with the...
pay attention to volume on 23rd july and short it now. Target $70
Bollinger bands are tight so it looks like this will break one way or the other in the near future. A clear uptrend must be in place and the trendline BC must be broken. BC leg has been broken but not quite a clear uptrend in place yet. Entry can be where you feel comfortable as there is a lot of R overhead. This one has a history of gapping down so be safe. I...
Emergent BioSolutions is well known for owning the rights to the pioneering technology behind the Narcan nasal spray. Naloxone has been around for years as an injectable for opioid overdoses which required expertise to administer. Narcan spray eliminated the expertise requirement. Recently, EBS entered into several large contracts with giant pharma and will...
EBS: Emergent BioSolutions 2020-08-17 06:30:10 Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
$EBS just broke out after earning results. I would wait a pull back before get in. 12 months Consensus Price Target: $90.14 if you find my charts useful, please leave me "like" or "comment". Please don't trade according to the ideas, rely on your own knowledge. Thx
This stock goes up, then gaps down, goes up, gaps down. Would not be fun to own a whole lot of it! Is a virus stock so I am sure gaps are probably based on news No pattern in particular..just a gap stock/volatile as a vocano.. providing support and resistance Earnings 7-30 amc and they do miss at times/short is not as high right now as I would think/perhaps it...
Not Trading or Investment Advice!!! My breakout algo issued a buy signal on 6/5. Buy at 86.91 Wait for update on exit price Risk control: use 3% of portfolio capital
Emergent BioSolutions is trying to break $71.19. RSI is below the trend and volume is not enough yet to get over
Wonderful classic setup- hyper growth facing a strong level! I do not care about the fundamentals. I just know, that facing a good level is a great opportunity for people to cover their longs and take profit. So, unless we see an instant breakout, and the price stops at the level, people will start covering parts of their positions, and the big buyer will stop...